Envestnet Portfolio Solutions, Inc. Ligand Pharmaceuticals Inc Transaction History
Envestnet Portfolio Solutions, Inc.
- $23.8 Billion
- Q3 2025
A detailed history of Envestnet Portfolio Solutions, Inc. transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Envestnet Portfolio Solutions, Inc. holds 1,560 shares of LGND stock, worth $298,334. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,560Holding current value
$298,334% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding LGND
# of Institutions
304Shares Held
20.1MCall Options Held
9KPut Options Held
0-
Black Rock Inc. New York, NY2.87MShares$549 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.09MShares$400 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X01.06MShares$203 Million0.06% of portfolio
-
Macquarie Group LTD Australia, C3927KShares$177 Million0.13% of portfolio
-
State Street Corp Boston, MA750KShares$143 Million0.0% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $3.23B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...